Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Venlafaxine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1481354A details a cost-effective nickel-catalyzed hydrogenation route for phenethylamine derivatives, offering significant supply chain advantages over rhodium methods.
Advanced catalytic process for 1-[cyano(phenyl)methyl]cyclohexanol compounds. High-purity Venlafaxine intermediate manufacturing with reduced costs and scalable supply chain solutions.
Patent CN115650863A reveals a 4-step route to Venlafaxine HCl with 67% yield. Ideal for cost-effective API manufacturing and scalable supply chains.
Novel patent CN109665966A offers cost-effective desvenlafaxine succinate synthesis. High yield, scalable process for reliable pharmaceutical intermediate supply chain.
Novel low-temperature demethylation process ensures high purity desmethylvenlafaxine intermediate with significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101503365A details a mild NaBH4/I2 reduction for Venlafaxine intermediates, offering high purity and cost-effective scalable manufacturing for global supply chains.
Novel synthesis route for desvenlafaxine succinate offering high purity and cost reduction for pharmaceutical supply chains ensuring reliable global availability and quality.
Novel patent CN113402400B offers high-purity desmethylvenlafaxine synthesis with reduced cost and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN1267410C reveals a safer, high-yield route for cyclohexanol derivatives using amidine catalysts, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN114292198A details a high-yield dehydration route for Venlafaxine impurity. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN112778143A discloses a novel 3-step synthesis for Venlafaxine Amine Impurity I. Achieve >99% purity for QC testing with cost-effective raw materials.
Patent CN112094230A details a novel synthesis for Venlafaxine Related Substance I. Discover cost-effective routes for high-purity pharmaceutical impurity standards.
Novel 3-step synthesis of Venlafaxine Impurity E via AlCl3/NaBH4 reduction. High purity (>99%), safe, scalable process for API quality control standards.
Patent CN1276913C details a high-yield aqueous method for venlafaxine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.